Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

499 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects.
Maniscalco GT, Ferrara AL, Liotti A, Manzo V, Di Battista ME, Salvatore S, Graziano D, Viola A, Amato G, Moreggia O, Di Giulio Cesare D, Alfieri G, Di Iorio W, Della Rocca G, Andreone V, De Rosa V. Maniscalco GT, et al. Among authors: viola a. Mult Scler Relat Disord. 2022 Jun;62:103800. doi: 10.1016/j.msard.2022.103800. Epub 2022 Apr 12. Mult Scler Relat Disord. 2022. PMID: 35462168 Free PMC article.
Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects.
Maniscalco GT, Manzo V, Ferrara AL, Perrella A, Di Battista M, Salvatore S, Graziano D, Viola A, Amato G, Moreggia O, Di Giulio Cesare D, Barbato S, Servillo G, Longo K, Di Giovanni M, Scarpati B, Muggianu SM, Longo G, Russo G, Andreone V, De Rosa V. Maniscalco GT, et al. Among authors: viola a. Mult Scler Relat Disord. 2022 Feb;58:103455. doi: 10.1016/j.msard.2021.103455. Epub 2021 Dec 18. Mult Scler Relat Disord. 2022. PMID: 34929455 Free PMC article.
Autoimmune encephalitis: A retrospective monocentric experience.
Maniscalco GT, Manzo V, Napolitano M, Ranieri A, Renna R, Servillo G, Alfieri G, Candelaresi P, Iorio WD, Rippa M, Bozzetti S, Zeccolini F, Gatta LD, Viola A, Santangelo C, Peluso R, Ferrari S, Mariotto S. Maniscalco GT, et al. Among authors: viola a. Mult Scler Relat Disord. 2021 Oct;55:103191. doi: 10.1016/j.msard.2021.103191. Epub 2021 Aug 6. Mult Scler Relat Disord. 2021. PMID: 34388533 No abstract available.
Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation.
Iannotta R, Celentano M, Marotta S, Pedata CM, Riccardi C, Migliaccio I, Viola A, Muggianu SM, Falco C, Bovenzi D, Ferrara F, Picardi A. Iannotta R, et al. Among authors: viola a. Leuk Res Rep. 2022 Jul 27;18:100340. doi: 10.1016/j.lrr.2022.100340. eCollection 2022. Leuk Res Rep. 2022. PMID: 35958243 Free PMC article.
Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myeloma.
Annunziata M, Celentano M, Pocali B, D'Amico MR, Palmieri S, Viola A, Copia C, Falco C, Del Vecchio L, Ferrara F. Annunziata M, et al. Among authors: viola a. Ann Hematol. 2006 Jun;85(6):394-9. doi: 10.1007/s00277-005-0058-0. Epub 2006 Mar 15. Ann Hematol. 2006. PMID: 16538502 Clinical Trial.
Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype.
Palmieri S, Ferrara F, Leoni F, Ciolli S, Pollio F, D'Amico MR, Celentano M, Viola A, Vicari L, Izzo B, Pane F. Palmieri S, et al. Among authors: viola a. Hematol Oncol. 2007 Mar;25(1):1-5. doi: 10.1002/hon.794. Hematol Oncol. 2007. PMID: 17036374
499 results